Literature DB >> 454921

Does DPI [(3,4-dihydroxy-phenylamino)-2-imidazoline] act at dopamine receptors on cortical neurones? [proceedings].

P Bevan, C M Bradshaw, R Y Pun, N T Slater, E Szabadi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 454921      PMCID： PMC2043798     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  4 in total

1.  The pharmacology of adrenergic neuronal responses in the cerebral cortex: evidence for excitatory alpha- and inhibitory beta-receptors.

Authors:  P Bevan; C M Bradshaw; E Szabadi
Journal:  Br J Pharmacol       Date:  1977-04       Impact factor: 8.739

2.  Responses of single cortical neurones to noradrenaline and dopamine.

Authors:  P Bevan; C M Bradshaw; R Y Pun; N T Slater; E Szabadi
Journal:  Neuropharmacology       Date:  1978-08       Impact factor: 5.250

3.  (3,4-Dihydroxy-phenylamino)-2-imidazoline (DPI), a new potent agonist at dopamine receptors mediating neuronal inhibition.

Authors:  H Struyker Boudier; L Teppema; A Cools; J Van Rossum
Journal:  J Pharm Pharmacol       Date:  1975-11       Impact factor: 3.765

4.  Dopamine receptors: selective agonists and antagonists of functionally distinct types within the feline brain.

Authors:  A R Cools; A J Boudier; J M Rossum
Journal:  Eur J Pharmacol       Date:  1976-06       Impact factor: 4.432
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.